Article Synopsis

  • Viruses have developed various strategies to evade the host's immune system, particularly by affecting pattern recognition receptors like cGAS.
  • Researchers discovered that the long non-coding RNA4.9 produced by human cytomegalovirus (HCMV) inhibits the immune response mediated by cGAS, promoting viral infection in human cells.
  • By blocking RNA4.9's interaction with cGAS using antisense oligonucleotides, researchers can restore cGAS activity and hinder HCMV replication, suggesting viral non-coding RNAs could be targeted for new therapeutic approaches.

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Viruses have evolved diverse immune evasion strategies, including the targeting of host pattern recognition receptors. The role of viral non-coding RNAs in modulating pattern recognition receptor activity is unclear. Here we show that human cytomegalovirus (HCMV) produces long non-coding RNA4.9 that counteracts the nuclear cyclic GMP-AMP synthase (cGAS)-mediated immune response to facilitate viral infection in human foreskin fibroblasts. RNA4.9 interacts with host cGAS via its 75-nucleotide RNA region with predicted hairpin loops. Binding of RNA4.9 to cGAS inhibits cGAS enzymatic activity as well as downstream interferon response and facilitates productive viral replication. Sterically blocking the folding of the 75-nucleotide region with antisense oligonucleotides during HCMV infection restores cGAS activity and impairs viral replication. In addition, we found that the specific localization of RNA4.9, which concentrates near HCMV DNA, is correlated with its efficient binding to cGAS and subsequent immune suppression. Our findings identify viral non-coding RNAs as key regulators of cGAS and highlight their potential as therapeutic targets.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41564-025-02078-5DOI Listing

Publication Analysis

Top Keywords

human cytomegalovirus
8
long non-coding
8
counteracts nuclear
8
immune evasion
8
pattern recognition
8
viral non-coding
8
non-coding rnas
8
viral replication
8
cgas
7
viral
5

Similar Publications

Refractory cytomegalovirus (CMV) infection is a severe complication following umbilical cord blood transplantation (UCBT). Antiviral agents, the standard first-line therapy, are limited by toxicity and resistance without robust T-cell immunity. We evaluated third-party donor (TPD)-derived CMV-specific T cells (CMVSTs) as a treatment option.

View Article and Find Full Text PDF

Background/aims: In cytomegalovirus-induced anterior uveitis (CMV-AU), frequent recurrences are the primary cause of glaucomatous damage and corneal endothelial cell loss, yet factors influencing such recurrences remain unclear. Our study aims to investigate the impact of glaucoma surgery (GS) on recurrence rate in patients with CMV-AU.

Methods: This retrospective study included 149 immunocompetent patients with CMV-AU treated with antiviral medication following PCR confirmation.

View Article and Find Full Text PDF

Mycoplasma genitalium can cause urinary tract infections and nonchlamydial, nongonococcal urethritis. Recent studies have suggested that M. genitalium is associated with sexually transmitted diseases, particularly among men who have sex with men.

View Article and Find Full Text PDF

Haploidentical vs. Matched Sibling Donor HCT in Racially Diverse Pediatric and AYA Patients with Hematologic Malignancies: A Single-Center Comparison.

Transplant Cell Ther

September 2025

Department of Pediatrics, University of Arizona, Tucson, AZ, USA; Banner University Medical Center, Tucson, AZ, USA; BIO5 Institute, University of Arizona, Tucson, AZ, USA; The University of Arizona Cancer Center, Tucson, AZ, USA; Department of Immunobiology, University of Arizona, Tucson, AZ, USA;

Background: Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment for pediatric patients with hematologic malignancies. Human leukocyte antigen (HLA)-matched sibling donors (MSDs) are considered the optimal source for stem cell transplantation; however, up to 70% of patients lack an MSD. This disparity is particularly pronounced among racial and ethnic minorities, who face challenges in identifying matched unrelated donors (MUDs).

View Article and Find Full Text PDF